Dana-Farber Research News 01.15.2026 - Takeaways - MDSpire

Dana-Farber Research News 01.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from December 16 - 31.

  • By

  • January 15, 2026

  • 14 min

Share

  • 1

    Dana-Farber's newsletter highlights research by faculty published from December 16 to 31, 2025.

  • 2

    Acalabrutinib shows promise for treating chronic lymphocytic leukemia in frail patients.

  • 3

    MECOM promotes aggressive acute myeloid leukemias by repressing differentiation gene programs.

  • 4

    BCL-w dimer inhibits BAX oligomerization, affecting apoptosis through membrane interactions.

  • 5

    Automated AI assessment of lymph nodes improves risk stratification in oropharyngeal carcinoma.

Original Source(s)

Dana-Farber Research News 01.15.2026

  • by

  • January 15, 2026

Related Content

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity